dbo:abstract
|
- Canagliflozin/metformin, sold under the brand name Vokanamet among others, is a fixed-dose combination anti-diabetic medication used for the treatment of type 2 diabetes. It is used in combination with diet and exercise. It is taken by mouth. The most common side effects include hypoglycemia (low blood glucose levels) when used in combination with insulin or a sulphonylurea and vulvovaginal candidiasis (thrush, a fungal infection of the female genital area caused by Candida). Canagliflozin/metformin was approved for medical use in the European Union in April 2014, and for use in the United States in August 2014. (en)
|
dbo:alternativeName
|
- Vokanamet, Invokamet (en)
|
dbo:casNumber
| |
dbo:kegg
| |
dbo:wikiPageExternalLink
| |
dbo:wikiPageID
| |
dbo:wikiPageLength
|
- 9232 (xsd:nonNegativeInteger)
|
dbo:wikiPageRevisionID
| |
dbo:wikiPageWikiLink
| |
dbp:atcPrefix
| |
dbp:atcSuffix
| |
dbp:casNumber
| |
dbp:class
| |
dbp:component
|
- Canagliflozin (en)
- Metformin (en)
|
dbp:dailymedid
| |
dbp:kegg
| |
dbp:legalEu
| |
dbp:legalStatus
| |
dbp:legalUk
| |
dbp:legalUs
| |
dbp:routesOfAdministration
| |
dbp:tradename
|
- Vokanamet, Invokamet (en)
|
dbp:type
| |
dbp:wikiPageUsesTemplate
| |
dcterms:subject
| |
rdf:type
| |
rdfs:comment
|
- Canagliflozin/metformin, sold under the brand name Vokanamet among others, is a fixed-dose combination anti-diabetic medication used for the treatment of type 2 diabetes. It is used in combination with diet and exercise. It is taken by mouth. The most common side effects include hypoglycemia (low blood glucose levels) when used in combination with insulin or a sulphonylurea and vulvovaginal candidiasis (thrush, a fungal infection of the female genital area caused by Candida). (en)
|
rdfs:label
|
- Canagliflozin/metformin (en)
|
rdfs:seeAlso
| |
owl:sameAs
| |
prov:wasDerivedFrom
| |
foaf:homepage
| |
foaf:isPrimaryTopicOf
| |
is dbo:wikiPageRedirects
of | |
is dbo:wikiPageWikiLink
of | |
is foaf:primaryTopic
of | |